The Future of Breast Cancer Treatment: From Conventional Wisdom to Nanotechnology-Enabled Precision
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27052109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Neetika Kimta und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological and Environmental Sciences, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Nanotechnology, Precision Medicine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer remains a leading cause of mortality among women worldwide, presenting significant treatment challenges due to its aggressive nature and lack of targeted therapies. Traditional treatments, including surgery, radiation, and chemotherapy, have improved survival rates. However, limitations such as drug resistance and adverse side effects persist. Recent advancements in nanotechnology offer promising avenues for enhancing breast cancer treatment by improving drug delivery, increasing therapeutic efficacy, and minimizing systemic toxicity. This review explores breast cancer’s pathophysiology and molecular mechanisms, evaluates current diagnostic and therapeutic strategies, and discusses emerging innovations in nanotechnology and integrative medicine. Recent studies have demonstrated the efficacy of green nanotechnology in transforming Ayurvedic medicine into scientifically credible treatments. These integrative approaches not only enhance the therapeutic potential of traditional medicine but also offer a pathway to overcome challenges associated with conventional cancer treatments. The convergence of nanotechnology and traditional medical systems holds transformative potential in breast cancer therapy. By leveraging the unique properties of nanoparticles and nanorobotics, it is possible to develop more effective, personalized, and less toxic treatment modalities. Future research should optimize these integrative approaches, conduct rigorous clinical trials, and elucidate the underlying mechanisms to fully realize their potential in combating breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological and Environmental Sciences, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India.
- Department of Biology, Chemistry and Environmental Sciences, College of Arts and Sciences, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates.
- Advanced Biosciences and Bioengineering Research Center, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates.
- Bioinformatics and Computational Biology Research Group, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates.
ORCID-Profile: Amin F Majdalawieh
Zitieren
APA
Kimta, N., Majdalawieh, M. A., & Majdalawieh, A. F. (2026). The Future of Breast Cancer Treatment: From Conventional Wisdom to Nanotechnology-Enabled Precision. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052109
Vancouver
Kimta N, Majdalawieh MA, Majdalawieh AF. The Future of Breast Cancer Treatment: From Conventional Wisdom to Nanotechnology-Enabled Precision. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052109
BibTeX
@article{Kimta2026,
author = {Kimta, Neetika and Majdalawieh, Malak A and Majdalawieh, Amin F},
title = {The Future of Breast Cancer Treatment: From Conventional Wisdom to Nanotechnology-Enabled Precision},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27052109}
}
EUVIMED